Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Intractable depression or psychosis.

N J Rubin1, J M Arceneaux

  • 1Department of Psychiatry and Neurology, College of Community Health Science, University of Alabama School of Medicine, Tuscaloosa, AL 35487-0326, USA.

Acta Psychiatrica Scandinavica
|November 28, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Abuse history: is it really important in the medical encounter?

Southern medical journal·1999
Same author

Health care perceptions of the standardized patient.

Medical education·1999
Same author

Developmental and sex differences in sensory and motor functioning.

The International journal of neuroscience·1997
Same author

Validity and reliability of rapidly alternating movement tests.

The International journal of neuroscience·1997
Same author

Perinatal risk factors as predictors of developmental functioning.

The International journal of neuroscience·1994
Same author

Neuropsychological significance of IQ summary scores.

The International journal of neuroscience·1994
Same journal

Developmental Trauma as a Prognostic Factor for Later Psychotic Disorder in an Adolescent Clinical Cohort: A 20-Year Follow Up Study.

Acta psychiatrica Scandinavica·2026
Same journal

The Prevalence of Obstructive Sleep Apnoea in Schizophrenia, Bipolar Disorder and Major Depressive Disorder: A Systematic Review With Meta-Analysis.

Acta psychiatrica Scandinavica·2026
Same journal

Use of Glucagon-Like Peptide 1 Receptor Agonists and the Associated Risk of Hospitalisation in Bipolar Disorder, From a Nationwide Cohort, 2009-2024.

Acta psychiatrica Scandinavica·2026
Same journal

Benzodiazepine Use and Mortality Risk: A Nationwide Cohort Study on New Benzodiazepine Users With a 5-Year Follow-Up.

Acta psychiatrica Scandinavica·2026
Same journal

Leveraging Family Genetic Risk Scores to Understand the Etiology of Suicidal Behaviors and Their Associations With Psychiatric Disorders.

Acta psychiatrica Scandinavica·2026
Same journal

Does the Loss of Autobiographical Memories Contribute to the Therapeutic Effect of Electroconvulsive Therapy?

Acta psychiatrica Scandinavica·2026
See all related articles

Treatment-resistant depression may mask an underlying thought disorder. The Rorschach test identified this in a patient, and low-dose risperidone successfully treated the condition, improving outcomes for this specific patient group.

Area of Science:

  • Psychiatry
  • Clinical Psychology

Background:

  • Treatment-resistant depression (TRD) affects a significant patient population.
  • Identifying comorbid conditions is crucial for effective TRD management.

Observation:

  • A 67-year-old female presented with intractable depression.
  • Subtle thought disorders can significantly impair quality of life in patients with depression.

Findings:

  • The Rorschach Exner Comprehensive System indicated a thought disorder, with positive scores on the Schizophrenia and Depression Indices.
  • Adding low-dose risperidone to the patient's regimen resulted in excellent clinical improvement.
  • Post-treatment assessment revealed normalization of the Schizophrenia and Depression Indices.

Implications:

Related Experiment Videos

  • The Rorschach test can identify thought disorders in patients with TRD.
  • Low-dose antipsychotic medication may be an effective treatment for this subgroup.
  • This case highlights a potential therapeutic strategy for previously unrecognized conditions in TRD.